Genetic determinants of immune-related adverse events in patients with melanoma receiving immune checkpoint inhibitors.
Noha Abdel-WahabAdi DiabRobert K YuAndrew FutrealLindsey A CriswellJean H TayarRamona DaduVickie ShannonSanjay S SheteMaria E Suarez-AlmazorPublished in: Cancer immunology, immunotherapy : CII (2021)
Several genetic variants associated with irAEs were identified. Additional larger studies are needed to validate these findings and establish their potential functional relevance.